Skip to Content

Higher Hb Threshold for Transfusion Not Better for Preemies

WEDNESDAY, Jan. 13, 2021 -- Use of a higher hemoglobin transfusion threshold does not lower the risk for death or neurodevelopmental impairment at 22 to 26 months of age among extremely low-birth-weight infants with anemia, according to a study published in the Dec. 31 issue of the New England Journal of Medicine.

Haresh Kirpalani, M.D., from the University of Pennsylvania in Philadelphia, and colleagues conducted a multicenter trial involving infants with a birth weight of 1,000 g or less and a gestational age between 22 weeks zero days and 28 weeks six days. Within 48 hours of delivery, 1,824 infants were randomly assigned to receive red-cell transfusions at either higher or lower hemoglobin thresholds until 36 weeks of postmenstrual age or discharge; primary outcome data were available for 1,692 infants.

Throughout the treatment period, there was a between-group difference of 1.9 g/dL in the pretransfusion mean hemoglobin levels. The researchers found that 50.1 percent of the 845 infants in the higher-threshold group died or survived with neurodevelopmental impairment compared with 49.8 percent of 847 infants in the lower-threshold group (relative risk adjusted for birth-weight stratum and center, 1.00; 95 percent confidence interval, 0.92 to 1.10; P = 0.93). The incidences of death (16.2 and 15.0 percent, respectively) and neurodevelopmental impairment (39.6 and 40.3 percent, respectively) were similar for the higher- and lower-threshold groups at two years.

"These results are consistent with the failure of erythropoietin to improve cognitive or other neurodevelopmental outcomes despite increasing red-cell mass," the authors write.

One author disclosed financial ties to Mednax.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Posted: January 2021

Read this next

Exercise Key to Lowering Risk for Gestational Diabetes

THURSDAY, Jan. 14, 2021 -- Exercise during the first trimester of pregnancy reduces the risks for abnormal glucose screening and gestational diabetes mellitus (GDM), according to...

Pregnancy Outcomes Examined for Women With Multiple Sclerosis

WEDNESDAY, Jan. 13, 2021 -- Women with pregnancy after versus before a multiple sclerosis (MS) diagnosis have fewer children and at an older age, according to a study published in...

Machine Learning Models Can Predict Gestational Diabetes

THURSDAY, Jan. 7, 2021 -- Machine learning (ML) models are highly accurate for predicting gestational diabetes mellitus (GDM) in early pregnancy in a Chinese population, according...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.